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Recent studies have demonstrated that the skin of
a normal adult human contains 10–20 billion resident
memory T cells, including various helper, cytotoxic,
and regulatory T cell subsets, that are poised to
respond to environmental antigens. Using only auto-
logous human tissues, we report that both in vitro
and in vivo, resting epidermal Langerhan cells (LCs)
selectively and specifically induced the activation
and proliferation of skin resident regulatory T (Treg)
cells, a minor subset of skin resident memory T cells.
In the presence of foreign pathogen, however, the
same LCs activated and induced proliferation of
effector memory T (Tem) cells and limited Treg cells’
activation. These underappreciated properties of
LCs, namely maintenance of tolerance in normal
skin, and activation of protective skin resident
memory T cells upon infectious challenge, help clarify
the role of LCs in skin.
INTRODUCTION
It was recently demonstrated that there are an estimated
20 billion T cells in the skin of an adult human, with virtually all
of them bearing markers that identify them as skin homing
memory T cells (CD45RO/CLA/CCR4) (Clark et al., 2006a). Not
only are there twice as many T cells in skin as in blood, but
more than 20-fold more memory T cells with a skin homing
phenotype can be found in skin rather than blood. In mouse
models of skin infection (Jiang et al., 2012) and presumably in
humans, these cells accumulate over time and are thought to
represent a compendium of T cell memory to antigens encoun-
tered through skin (Clark, 2010). Recent studies from human
CTCL patients treated with alemtuzumab demonstrate an abun-
dant population of nonmalignant normal skin resident effector
memory T (Tem) cells that do not readily recirculate and that
appear to protect the host from infection locally (Clark et al.,
2012). Skin dendritic cells can readily present antigen to skin
resident memory T cells, a process that can occur immediately
after pathogen invasion of skin and that require no cellular
recruitment or migration from blood (Heath and Carbone,
2009; Wakim et al., 2008; Jiang et al., 2012). However, moststudies on the role of dermal DCs or LCs have examined their
capacity to stimulate naive T cells (Fujita et al., 2009; Furio
et al., 2010; Klechevsky et al., 2008; Mathers et al., 2009), an
interaction that can occur only after DCs or LCs have left skin,
migrated through afferent lymphatics, and ultimately entered
the T cell-rich area of the skin draining lymph node. Given their
respective strategic locations, from a purely stochastic perspec-
tive, it is as likely that skin resident DCs will encounter skin resi-
dent memory T cells in skin, rather than a naive T cell in lymph
node. However, because of the relatively recent discovery of
skin resident memory T cells, studies on the interaction of skin
resident DCs and skin resident memory T cells from the same
individual have not yet been published.
Human skin also contains a resident population of regulatory
T (Treg) cells that represent between 5% and 10% of the total
resident skin T cells (Clark et al., 2008; Clark and Kupper,
2007). To date, most human Treg cells studies analyzing their
phenotype or function have been performed on rare (1%–4%)
blood-derived effector CD45RO+FoxP3hi cells (Miyara et al.,
2009; Sakaguchi et al., 2010; Wing and Sakaguchi, 2010). These
effector CD45RO± Treg cells can suppress the proliferation and
cytokine production of effector T cells. Although these effector
Treg cells express CD45RO, which is the marker of conven-
tional memory T cells, no evidence for memory and recall
responses by these Treg cells has been previously demon-
strated in mouse experiments until recently. Indeed, effector
memory Treg cells have been shown to persist in skin and
induce tolerance to a transgenically expressed ‘‘autoantigen’’
in a mouse model (Rosenblum et al., 2011). However, little is
known about the function of effector CD45RO+ skin resident
memory Treg cells which populate peripheral human tissues
such as skin. We have previously demonstrated that human
skin Treg cells can proliferate in an antigen-independent
manner when cultured with IL-15 and dermal fibroblasts (Clark
and Kupper, 2007), conditions that can be seen in inflamed
tissue (Rappl et al., 2001). Moreover, another study showed
that skin human skin-resident memory Treg cells can locally
expand during cutaneous inflammation (Vukmanovic-Stejic
et al., 2008) and can serve as a brake to regulate the inflam-
mation in peripheral tissue (Dudda et al., 2008). More recently,
it was shown in a human model that glucocorticosteroids
can induce proliferation of Treg cells in skin (Stary et al.,
2011). Under normal conditions, however, the function and
homeostasis of human skin resident memory Treg cells remain
incompletely characterized.Immunity 36, 873–884, May 25, 2012 ª2012 Elsevier Inc. 873
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LCs Activate Skin Resident Regulatory T CellsNormal human skin contains also distinct populations of
dendritic cells (DCs): Langerhans cells (LCs) expressing CD1a
and Langerin/CD207 (Valladeau et al., 2000), and dermal resi-
dent DCs (DDCs) expressing CD1c, which is also known as
blood dendritic cell antigen (BDCA1) (Zaba et al., 2007; Zaba
et al., 2009). LCs mainly populate the epidermis and are tradi-
tionally considered as the first line of defense against exogenous
pathogen invasion (Merad et al., 2008). More recently, LC func-
tion has become more controversial, with some studies sug-
gesting their true role is not immune stimulation but rather
immunoregulation (Kaplan, 2010; Lutz et al., 2010). Studies in
transgenic mice have revealed a role for LCs in the induction of
tolerance. Data using LC-deficient mouse models indicated
that LC might actually dampen inflammation and mediate toler-
ance, especially in contact hypersensitivity reactions (Bobr et al.,
2010; Igyarto et al., 2009; Kaplan et al., 2005). At the same time,
human LCs have been found to be the most powerful DC subset
to induce the in vitro differentiation and the polarization of naive
CD4+ T cells into either Th2 (Furio et al., 2010) or Th17 (Mathers
et al., 2009) effector cell phenotypes, or more recently Th22
(Fujita et al., 2009) effector cell phenotypes. Moreover, human
LCs can also prime and cross-prime naive CD8+ T cells
(Klechevsky et al., 2008). Thus, there is substantial controversy
regarding the physiologic role of LCs with regard to immunoreg-
ulation versus immunostimulation (Stoitzner, 2010).
This paradox has been difficult to reconcile experimentally, in
part because of certain apparent differences between human
and murine skin. Langerin/CD207, an integral glycoprotein of
Birbeck granules that define human LCs (Valladeau et al.,
2000), is expressed by a subset of dermal DCs in mice that do
not have a clear counterpart in human skin (Bursch et al.,
2007). Moreover, many resident T cells in murine skin are
TCRgd+ and have a limited T cell receptor (TCR) repertoire
(Nanno et al., 2007), whereas T cells resident to human skin
are predominantly TCRab and have great TCR diversity (Clark
et al., 2006a). To further complicate matters, most human
studies of LCs have involved stimulation of allogeneic, rather
than autologous, naive T cells from peripheral blood, thus intro-
ducing a potential artifact into the system. These and other
differences make it difficult to directly compare experimental
results on human andmurine LC biology, or to extrapolate exper-
imental results involving murine LCs to human skin immunity.
Increasingly, the trend among immunologists has been to
address questions relevant to human immunology with human
models (Davis, 2008, 2012), as we have chosen to do here.
In the present study, we demonstrate that LCs induced the
proliferation of a subset of autologous skin resident memory
T cells in vitro. These proliferating T cells were exclusively
CD4+CD25+FoxP3+CD127 skin resident Treg cells, and their
function was demonstrated by suppression of proliferation of
autologous skin resident Tem cells. The LC-mediated prolifera-
tion of these skin resident memory Treg cells could be com-
pletely blocked by antibodies to class II MHC, as well as
CD80-86, suggesting MHC-restricted antigen presentation.
Moreover, the proliferation could be blocked with antibodies
to LC-derived IL-15 activity or T cell-derived IL-2. Immunohisto-
chemical analysis and FACS analysis of normal human skin re-
vealed that skin resident memory Treg cells were predominantly
located within or near the epidermis or follicular epithelium,874 Immunity 36, 873–884, May 25, 2012 ª2012 Elsevier Inc.always proximity to LCs. A subset of these skin resident
memory Treg cells were positive for Ki67 in situ, a cell cycle
antigen specific for recent or ongoing proliferation (Scholzen
and Gerdes, 2000), suggesting that what we observed in vitro
is occurring in vivo at steady state. Interestingly, when the
skin pathogen Candida albicans (C. albicans) was added to
the cocultures in vitro, an additional subset of T cells prolifer-
ated. Further analysis showed that not only skin resident
memory Treg cells but also antigen-specific skin resident Tem
cells subsets proliferated under these conditions and that the
skin resident Tem cells produced the effector cytokines IFN-g
and IL-17. These data suggest that under steady state condi-
tions in skin, LCs mediate tolerance to self antigens, but can
also be activated by infection to mediate protective immunity.
Thus, their capacity to negatively or positively modify immune
response depends upon context.
RESULTS
Langerhans Cells Induce Proliferation of Skin Resident
CD4+ T Cells in the Absence of Exogenous Antigen
We carefully extracted and purified LCs, dermal DCs, and
skin-resident memory T cells from the skin of multiple individual
donors (Figure S1 available online). We first isolated skin resident
memory T cells from normal human skin as previously described
(Clark et al., 2006a). Skin T cells are composed of CD45RO+
T cells expressing skin homing addressins CLA and CCR4 and
lacking coexpression of CCR7 and CD62L (Clark, 2010). In
parallel, we isolated cutaneous DC from the same donor. Skin
DC contained epidermal HLA-DR+CD207+ LC and dermal
HLA-DRhiBDCA1+ DC (DDC) (Zaba et al., 2007; Zaba et al.,
2009). Both LC and DDC expressed significant levels of CD86,
CD83 andDC-LAMP (Figure S2) as described in previous studies
(Bond et al., 2009; Klechevsky et al., 2008). Skin resident
memory T cells were then stained with carboxyfluorescein suc-
cinimidyl ester (CFSE) and cocultured in presence of purified
autologous skin DCs. After 6 days of coculture, T cell prolifera-
tion was assessed by flow cytometry. We observed a significant
expansion of skin resident memory T cells in the presence of
LCs, but no significant proliferation in the presence of DDCs.
Medium conditioned by LCs or DDCs had no effect on skin resi-
dent memory T cells proliferation (Figures 1A and 1B). Thus,
epidermal LCs were strong inducers of skin resident memory
T cell proliferation, whereas DDCs produced negligible prolifera-
tion (Figure 1C and Figure S3). Skin resident memory T cells
proliferation induced by LCs became observable between day
4 and 6 (Figures 1D and 1E).
We next explored the phenotype of the proliferative skin resi-
dent memory T population. Skin resident memory T cells were
cultured alone or in the presence of LCs. After 6 days, skin resi-
dent memory T cells were isolated and stained with antibodies
directed against CD3, CD4, and CD8. Strikingly, the proliferative
skin resident memory T cells were overwhelmingly CD4+ T cells
(96.7% ± 2.7% for four donors; Figures 2A and 2B), whereas the
nonproliferative cells were composed of a more substantial
fraction of CD8+ T cells.
Therefore, LCs but not DDCs induced the proliferation of skin
resident memory T cells, a process which required cell contact.
CD4+ T cells were preferentially stimulated.
Figure 1. A Subset of Skin Resident Memory T Cells Proliferates in Presence of Autologous LCs
(A) Proliferation of skin resident memory T cells labeled with CFSE and cultured alone, or with autologous DDCs or LCs at a ratio 2:1 after 6 days, or with
conditioned medium from LCs or DDCs. Proliferation as measured by CFSE dilution, from a representative experiment, is shown.
(B) Numbers indicate the percentage of proliferating CD3+ T cells.
(C) Percentage of proliferating CD3+ skin resident memory T cells, measured for multiple subjects (each sign represents a single subject, two-tailed, unpaired
t test).
(D) CFSE-labeled skin resident memory T cells were cocultured with autologous LCs, DDCs, or alone. Proliferation as measured by CFSE dilution, from
a representative experiment at different days, is shown.
(E) The graph shows the percentage of proliferating CD3+ skin-resident memory T cells, measured for two independent experiments with duplicate.
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LCs Activate Skin Resident Regulatory T CellsThe Proliferating Skin-Resident Memory T Cells Are
Treg Cells
In normal human skin, resident memory T cells contain a popula-
tion of skin-resident memory Treg cells that are CD4+CD25+
FoxP3+CD127, and we then examined whether the expansion
of T cells induced by LC in vitro might involve skin-resident
memory Treg cells. To address this issue, we again cultured
skin isolated CFSE-labeled skin resident memory T cells withpurified autologous LCs. At day 6, T cells were analyzed with
antibodies directed against CD4, CD25, FoxP3, and CD127 by
flow cytometry. Strikingly, in the expanded proliferative T cell
population, 84.8% ± 8% of the T cells were CD4+CD25+FoxP3+
CD127, CTLA-4+, GITR+, and CD69 compatible with a Treg
cell phenotype (Figures 3A and 3B and Figures S4A and S4B),
whereas the fraction of skin resident memory Treg cells in
the nonproliferative, skin-resident memory T cells subset wasImmunity 36, 873–884, May 25, 2012 ª2012 Elsevier Inc. 875
Figure 2. Proliferating Skin-Resident Memory T
Cells Are Preferentially CD4+ T Lymphocytes
(A) Proliferation of CD3+ CFSE labeled skin resident
memory T cells stimulated with autologous LCs. At day 6
of coculture, skin-resident memory T cells were stained for
CD4 and CD8 and proliferative and nonproliferative skin
resident memory T cells subsets were analyzed. Numbers
in quadrants indicate percent cells (representative
experiment).
(B) Percentage of CD4+ and CD8+ T cells in the prolifera-
tive population. The graph shows mean ± SD. Data are
representative of four independent experiments (two-
tailed, unpaired t test).
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LCs Activate Skin Resident Regulatory T Cellscomparable with the fraction observed in the control population.
Moreover, an actual absolute expansion of Treg cells with
a range of amplification from 1.5- to 3.0-fold was observed after
coculture with autologous LCs (Figure 3C). Deletion of a CD25+
skin resident memory T cell subset prior to coculture with autol-
ogous LCs significantly reduced the expansion of skin-resident
memory Treg cells (Figure 3D). Because phenotypic markers
do not measure Treg cell function, we next assessed the ability
of the expanded skin resident memory Treg cell population to
suppress T cell proliferation in a secondary MLR. The CD4+
CD25+CD127 skin resident memory Treg cells were harvested
and isolated after 6 days of coculture and then added to a MLR
composed of CFSE-labeled skin resident Tem cells and irradi-
ated PBMCs as stimulators. The addition of this activated
population of skin resident memory Treg cells reproducibly
and significantly inhibited autologous skin resident Tem cells
proliferation in this assay (Figure 3E) and showed that there
was >65% suppression of such responses at a 1:1 ratio. These
results were confirmed in additional experiments in with a [3H]
thymidine incorporation assay (Figure 3F). Again, isolated CD4+
CD25+CD127 skin resident memory Treg cells strongly in-
hibited the proliferation of skin resident Tem cells. Therefore,
LCs specifically induced the proliferation of skin resident
memory Treg cells, but not skin-resident Tem cells, under
steady state conditions and these expanded skin resident
memory Treg cells showed potent suppressive activity. Taken
together, these results suggest that Treg cells, a minor popula-
tion among skin resident memory T cells, were specifically
induced to proliferate by LCs. These Treg cells demonstrated
a classical phenotype (CD4+CD25+FoxP3+CD127), and medi-
ated significant suppression of proliferation of skin resident
Tem cells.
LC-Mediated Skin Resident Memory Treg Cells
Proliferation Is Antigen Specific
We demonstrated above that LCs have the unique capacity to
induce proliferation of functional skin resident memory Treg
cells. To further understand which signals are involved in the
interaction between LC and skin resident memory T cells, we
cocultured CFSE-labeled skin resident memory T cells with
autologous LCs in the presence of different blocking anti-
bodies: anti-MHC class I and/or II, CD80-86, CD1a, IL-2, and
IL-15Ra. At day 6, expansion of skin CD3+ skin resident876 Immunity 36, 873–884, May 25, 2012 ª2012 Elsevier Inc.memory T cells was assessed by dilution of CFSE using flow
cytometry (Figures 4A and 4B). Blocking the MHC class II
presentation, and more specifically HLA-DR and DP, sig-
nificantly reduced the proliferation of skin resident memory
T cells (Figures 4C and 4D). Similarly, blocking the costimula-
tory signal CD80-86 or the addition of cytokine antibodies
directed against IL-2 or IL-15Ra significantly decreased the
induction of skin resident memory T cell proliferation (Figure 4B).
In contrast, the proliferation of skin resident memory Treg cells
was not dependent on CD1a or MHC class I presentation.
These data strongly suggest that proliferation of skin skin resi-
dent memory T cells by resident LCs proceeds in an antigen-
dependent manner.
Skin Resident Memory Treg Cells Are Located
in the Epidermis or at the Papillary Dermal-Epidermal
Junction, and Proliferate In Situ
We next examined whether we could detect interactions
between LCs and skin resident memory Treg cells in vivo. We
examined multiple specimens of freshly obtained human skin
by using immunofluoresencemicroscopy. As we have previously
described, abundant CD3+ skin resident memory T cells could
be identified in uninflamed human skin, and a subset of CD3+
skin resident memory T cells coexpressed nuclear FoxP3 and
CD25 (Figure S5A), identifying them as skin resident memory
Treg cells (Figure 5A). Interestingly, these skin resident memory
Treg cells appeared to be localized in or near the epidermis and
follicular epithelium, in contact or close proximity to CD1a+
epidermal and follicular LCs (Figure 5B and Figure S5C). We
next investigated whether these skin resident memory Treg cells
showed evidence for proliferation by examining expression of
the marker Ki67, which is expressed through all phases of the
cell cycle, but is absent in cells in G0. CD3+FoxP3+ skin resident
memory T cells that expressed Ki67 could be readily observed in
skin sections, whereas Ki67+ CD3+FoxP3 skin resident Tem
cells were undetectable. The CD3+FoxP3+Ki67+ skin resident
memory T cells were predominantly located in the epidermis,
follicular epithelium, or upper papillary dermis, rather than in
the deeper papillary or reticular dermis (Figure 5C and Figures
S5B and S5C). Moreover, we observed that CD1c/BDCA1+
DDCs were found in close proximity to FoxP3+ skin-resident
memory Treg cells in a resting state (Figure S5D). The strict asso-
ciation of Ki67 expression with cellular proliferation leads us to
Figure 3. Proliferating CD4+ Skin Resident
Memory T Cells in Presence of Autologous
LCs Are Functional Regulatory T Cells
(A) CFSE labeled skin resident memory T cells
were stimulated with autologous LCs. At day 6,
CD3+ skin resident memory T cells were stained
for CD4, CD25, CD127, and FoxP3. Numbers in
quadrants represent percentage.
(B) The percentage of CD4+CD25+FoxP3+CD127
regulatory T cells (skin resident memory Treg cells)
and nonregulatory skin resident memory T cells in
the proliferative population assessed for different
donors. The graph shows mean ± SD. Data are
representative of five independent experiments
(two-tailed, unpaired t test).
(C) Figure represents fold amplification of CD4+
CD25+FoxP3+CD127 Treg cells after 6 days of
coculture with autologous LCs relative to Treg
cells present at day 0. Each sign represents an
independent experiment; the bar represents the
mean.
(D) The depletion of CD25+ skin resident memory
T cells prior to coculture with autologous LCs
decreases the proliferation of skin resident
memory T cells. CFSE-labeled skin resident
memory T cells or CFSE labeled CD25 skin resi-
dent memory (T) cells were cocultured with autol-
ogous LC for 6 days. Proliferation was measured
by the dilution of CFSE. Numbers indicate
percentage of proliferative cells.
(E) Expanded skin resident memory Treg cells
from 6 day of cocultures were isolated and then
cultured with autologous CFSE-labeled skin resi-
dent Tem cells in presence of anti-CD3 (1 mg/ml)
and irradiated peripheral blood mononuclear cells
(iPBMCs). CFSE dilution was analyzed at day 5.
These data are representative of three in-
dependent experiments with cells from different
subjects.
(F) Expanded Treg cells were cultured with skin
resident Tem cells in the presence of anti-CD3
(1 mg/ml) and iPBMCs. After 4 days of coculture,
[3H]thymidine was added to each well. The cells
were harvested after 16 hr and radioactivity was
measured. The graph shows mean ± SD. Data are
representative of two independent experiments
with triplicate (two-tailed, unpaired t test).
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LCs Activate Skin Resident Regulatory T Cellsconclude that in vivo as well as in vitro, epidermal LCs induce
the proliferation of skin resident memory Treg cells, consistent
with a tolerogenic role for LCs at steady state. These results
showed that Treg cells and LCs colocalized in epidermis and
follicular epithelium and that a discernable population of these
Treg cells appeared to be entering the cell cycle, as judged by
Ki67 expression. These in vivo data are completely consistent
with the observations of LC-induced Treg cells proliferation
in vitro.
Abundant Skin Resident Memory T Cells, Including Skin
Resident Memory Treg Cells, Are Present in the
Epidermis by FACS Analysis
To confirm that skin resident memory T cells were indeed
present in epidermis, we subjected skin explants to dispase
treatment, which cleaves skin specifically at the dermal
epidermal junction without disrupting epidermal cell-cell interac-tions. Dermis and epidermis were then separated, enzymatically
digested, and analyzed independently. Skin resident memory
T cells were readily found in the epidermis (3% all cells), and
17% of these CD3+ cells were FoxP3+ skin resident memory
Treg cells. LCs were similarly abundant (1.2% of all cells), and
no cells with DDC markers were observed in the epidermal frac-
tion, confirming the specificity of the separation (Figure 6A).
Dermis contained a smattering of CD1a+ LCs (0.1%), and again
skin resident memory T cells were abundant (3.6% of all cells).
Approximately 70% fewer of these dermal skin resident memory
T cells were FoxP3+ skin resident memory Treg cells (6%), sug-
gesting that skin resident memory Treg cells are enriched in the
epidermal compartment (Figure 6B). Thus, our immunofluore-
sence histology observations are validated by FACS analysis
of the dermal and epidermal compartments; that is, LC and
skin resident memory Treg cells can be found together in the
epidermal compartment.Immunity 36, 873–884, May 25, 2012 ª2012 Elsevier Inc. 877
Figure 4. Expansion of Skin Resident Memory Treg Cells Is Dependent on MHC Class II, CD80-86, and IL-2 or IL-15
(A) Proliferation of CFSE labeled skin resident memory T cells cocultured with autologous LCs in the presence of the indicated neutralizing antibodies or isotype-
matched, nonreactive antibodies as control. Proliferation of CD3+ T cells was measured by CFSE dilution. Numbers represent the percent of divided cells for
a representative donor.
(B) Percentage of skin resident memory T cells proliferating in presence of neutralizing antibodies compared to matching isotype control. The graph shows
means ± SD. Data are representative of three independent experiments (two-tailed, unpaired t test).
(C) Proliferation of CD3+ T cells measured by CFSE dilution in the presence of different concentrations of pan-MHC class II blocker.
(D) Proliferation of CFSE-labeled skin resident memory T cells cocultured with autologous LCs in the presence of the indicated neutralizing antibodies or isotype-
matched control. Graph shows means ± SD and data are representative of two independent experiments with duplicate.
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LCs Activate Skin Resident Regulatory T CellsDuring Infection, LCs Induce Proliferation of Both
Memory Treg Cells and Pathogen-Specific Tem Cells
Present in the Skin
Our data strongly suggest that human LCs have the ability to
maintain peripheral tolerance by inducing local proliferation of
skin resident memory Treg cells. However, recent studies (Fujita
et al., 2009; Furio et al., 2010; Klechevsky et al., 2008; Mathers878 Immunity 36, 873–884, May 25, 2012 ª2012 Elsevier Inc.et al., 2009) on the biology and function of human LCs showed
their capacity to induce differentiation and expansion of naive
CD4+ T cells into potent Tem cells rather than Treg cells in
apparent contrast with our data. To further assess the function
of LCs in human skin, we analyzed the proliferation of skin resi-
dent memory T cells induced by autologous LCs in the presence
of C. albicans.Most immunocompetent individuals can manifest
Figure 5. Skin Resident Memory Treg Cells Are Found in the Epidermis near Langerhans Cells and Express the Proliferation Marker Ki67
(A) Immunofluorescence of skin showing expression of FoxP3 (green) and CD3 (red), FoxP3, CD3 double-positive regulatory T (Treg) cells are found mainly in the
epidermis and the papillary dermis.
(B) FoxP3+ skin resident memory Treg cells are found in close proximity to CD1a+ LCs (red).
(C) A proportion of FoxP3+ (green) Treg cells coexpress Ki67 (red), resulting in a yellow overlay. As shown in the right panel, a histogram shows the percentage of
FoxP3/Ki67 double-positive cells in the FoxP3+ population in epidermis/papillary dermis or dermis. The graph showsmean ± SD and data are representative of six
independent donors (two-tailed, unpaired t test). Scale bars represent 50 mm (bottom left) and 10 mm (bottom right).
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LCs Activate Skin Resident Regulatory T Cellsa delayed type hypersensitivity response toC. albicans, a ubiqui-
tous human skin commensal that can cause skin inflammation in
the setting of barrier disruption (Romani, 2000). C. albicans
applied to the surface of intact skin provokes no response, but
when injected intradermally, can induce T cell-mediated inflam-
mation that is evident by 24–48 hr (Esch and Buckley, 1988). We
have previously shown that most individuals have skin resident
memory T cells that can respond in vitro to C. albicans, both
via proliferation and IL-17 and IFN-g production. We asked
whether LCs would present C. albicans antigens to skin resident
memory T cells in an immunogenic or tolerogenic fashion. In nine
out of ten donors, addition of C. albicans antigen led to substan-
tially increased proliferation of skin-resident memory T cells
(Figures 7A and 7B) and proliferating skin resident memory
T cells included both FoxP3+CD127 and FoxP3 CD127+
T cells, indicating that both skin resident memory Treg cells
and skin resident Tem cells were proliferating (Figure 7C). Inter-
estingly, low doses ofC. albicans antigen favored Treg cell prolif-
eration, whereas higher doses favored Tem cell proliferation
(Figure 7D). This is consistent with the observation that Treg cells
are most effective at lower levels of antigen. Moreover, depletion
of CD25+ Treg cells is associated with increased proliferation
in the presence of C. albicans, suggesting the removal of Treg
cell inhibition on specific C. albicans Tem cells expansion
(Figure 7E).The proliferation of skin resident memory T cells to C. albicans
could be blocked completely by antibodies to class II MHC and
CD80/86, as well as antibodies to IL-2 and IL-15Ra (Figure S6).
Proliferating cells produced IL-17 and IFN-g (Figure S7A) and
were enriched for Vb2, Vb3, and Vb8 abTCR T cells (Figure S7B).
Interestingly, there was a highly reproducible >50% inhibition of
proliferation with a blocking antibody to CD1a, which had no
effect on skin resident memory Treg cell proliferation in the
absence of C. albicans. Taken together, these data suggest
that after pathogenic antigen exposure, LCs induced prolifera-
tion of pathogen-specific Tem cells as well as Treg cells. Thus,
depending upon the biological context, LCs can mediate toler-
ance or immunity.
DISCUSSION
There are several features of our study that have not been previ-
ously reported, and these are discussed below. First, we have
examined the function of LCs in normal human skin and, most
importantly, the interaction of LC with skin resident memory
T cells, a population first described in 2006 (Clark et al.,
2006a). These studies are made possible by technical
advances—specifically, our ability to extract large numbers of
skin resident memory T cells from human skin, as we have
described previously (Clark et al., 2006b). Virtually all skinImmunity 36, 873–884, May 25, 2012 ª2012 Elsevier Inc. 879
Figure 6. Skin Resident Memory Treg Cells Are Abundant in Epidermis
Epidermal and dermal layers from skin explants were separated using dispase treatment. As shown in (A), epidermal cells contained abundant CD3+ skin resident
memory T cells and are enriched for FoxP3+ skin resident memory Treg cells. CD1a+ LC were also abundant in epidermis. As shown in (B), skin resident memory
T cells were abundantly present in dermis with fewer skin-resident memory Treg cells than epidermis. No substantial CD1a+ LCs were found in dermis. Numbers
in quadrant indicate the percentage of cells.
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LCs Activate Skin Resident Regulatory T Cellsresident memory T cells have memory (CD45RO) and skin
homing (CLA, CCR4) markers, most have a Tem cell phenotype,
and all are thought to be derived from prior antigen encounters in
skin draining lymph nodes (Clark, 2010). Indeed, recent mouse
models have indicated that it is these skin resident memory
T cells, rather than circulating T cells or antibodies, that mediate
host defense upon microbial challenge (Gebhardt et al., 2009;
Liu et al., 2010; Jiang et al., 2012). More recently, this was vali-
dated in a model of human disease (Clark et al., 2012). Thus,
the interaction between skin resident dendritic cells (including
LCs) and skin resident memory T cells is likely to be essential
for rapid recall or memory responses in skin to proceed. In
contrast, most recent papers describe human LC interactions
with naive T cells (Fujita et al., 2009; Furio et al., 2010; Klechev-
sky et al., 2008;Mathers et al., 2009), a process that requires LCs
to exit the epidermis and migrate down dermal afferent
lymphatics to the lymph node and that is most relevant to
primary immune responses. We do not suggest that these
studies are less important, only that they describe the biology
of primary rather than memory responses.
Second, we describe the capacity of LCs, but not dermal DCs,
to induce the proliferation of a subset of skin resident memory
T cells, specifically CD4+CD25+FoxP3+CD127 T cells that
have the phenotype of Treg cells (Liu et al., 2006). This prolifera-
tion appears to be dependent upon antigen presentation, given
that it can be inhibited completely by antibodies to either class
II MHC or CD80-86. In contrast, antibodies to MHC class I or
CD1a had no effect. The proliferation could also be blocked by
antibodies to IL-2 and IL-15 activity, cytokines derived from
T cells (Waldmann, 2006), or LCs (Mu¨nz et al., 2005; Ratzinger
et al., 2004), respectively. These data are consistent with LCs
presenting antigen to skin resident memory Treg cells. Although
it is tempting to speculate that it is self-antigen that is being pre-880 Immunity 36, 873–884, May 25, 2012 ª2012 Elsevier Inc.sented, we cannot rule out the possibility that there is some
contribution of normal skin flora antigens in our culture condi-
tions. However, a recent report in a K5-ovalbumin expressing
murine model demonstrated that self-reactive skin resident
memory Treg cells could be generated and persist in skin. These
memory Tregcells could reduce andultimately suppress anauto-
immune T cell-mediated skin disease (Rosenblum et al., 2011).
Supporting the idea that epidermal LCs and skin resident
memory Treg cells have ample opportunity to interact in vivo,
our FACS analysis of dermal and epidermal compartments
confirm that skin resident memory T cells in general are abun-
dant in epidermis and dermis and that skin-resident memory
Treg cells in particular are more abundant in epidermis than
dermis. Immunohistochemical studies demonstrate that skin
resident memory Treg cells are localized to either the epidermis
or the dermal epidermal junction and overlap with CD1a+ LCs. A
reproducible fraction (5%) of these skin resident memory Treg
cells is positive to Ki67. Ki67 is generally considered a prolifera-
tion marker and is present during all phases of the cell cycle, but
is absent in resting (G0) cells (Scholzen and Gerdes, 2000). This
in vivo finding is completely consistent with our in vitro observa-
tion that LCs selectively induce proliferation of the skin resident
memory Treg cells subset of skin resident T cells. Although the
immunostaining data show that skin resident memory Treg cells
are the most abundant skin resident T cells to interact with LCs
in vivo, the in vitro proliferation data indicate that even when
skin resident memory Treg cells are a minority population,
they are still preferentially induced to proliferate by LCs from
normal skin.
Phenotype does not prove function (Sakaguchi et al., 2010),
and thus we felt it necessary to determine whether our CD3+
CD4+FoxP3+CD127 could suppress Tem cell immune re-
sponses. We felt that the most relevant responder Tem cells
Figure 7. In the Presence of C. albicans, Both Skin Resident Tem and Treg Cells Proliferate
CFSE-labeled skin resident memory T cells were cocultured with autologous LCs in the presence or absence of heat-inactivated C. albicans for 6 days.
(A) Skin resident memory T cells were then stained for CD3. Numbers in quadrant show the percentage of expanded T cells.
(B) Data from ten independent experiments (two-tailed, unpaired t test).
(C) CFSE-labeled skin resident memory T cells stimulated with autologous LCs in the presence of heat-inactivated C. albicans. At day 6, CD3+ skin resident
memory T cells were stained for CD4, CD25, CD127, and FoxP3. Numbers in quadrants represent percent cells in proliferative and nonproliferative populations.
Data are representative of three independent experiments.
(D) The graph shows percent skin resident memory Treg cells and skin resident Tem cells in the proliferative populations when skin resident memory T cells and
LCs were cocultured with different ratio of C. albicans. Data are representative of two independent experiments with duplicate.
(E) Depletion of CD25+ increased the proliferation of skin resident Tem cells in the presence of pathogen. CFSE-labeled T cells or CD25 T cells were cocultured
with autologous LCs for 6 days in the presence of C. albicans. Proliferation was measured by the dilution of CFSE. Numbers indicate the percentage of divided
cells for a representative donor.
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same sample of skin. We were able to demonstrate quite clearly
that the addition of skin resident memory Treg cells substantially
blocked the proliferation of autologous skin resident Tem cells to
allogeneic antigen, by using as a read-out either CFSE dilution or
[3H]thymidine incorporation. Thus, LCs induced expansion of
skin resident memory Treg cells that can suppress autologous
skin resident Tem cell responses. Given the localization of these
cells in the epidermis and dermis, it is tempting to speculate thatLCs are activating skin resident memory Treg cells to maintain
tolerance to self antigens (Morelli et al., 2001; Morelli and Thom-
son, 2007). It is also possible that LCs could present antigens
from normal skin resident microbial flora to skin resident memory
Treg cells (Kubo et al., 2009). Further studies will determine
which of these potential roles is more relevant.
Most studies of human LCs have focused upon their potent
ability to activate and differentiate naive T cells in vitro. Preferen-
tial generation of Th2 (Furio et al., 2010), Th17 (Mathers et al.,Immunity 36, 873–884, May 25, 2012 ª2012 Elsevier Inc. 881
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has been noted, as has the cross-presentation of antigen to
CD8+ effector cells (Banchereau et al., 2009; Klechevsky et al.,
2008). As noted above, all such interactions occur physiologi-
cally in lymph nodes, the only possible site where LCs and naive
T cells will encounter each other. Given the paradox that LCs are
immunoregulatory within the skin in the absence of exogenous
antigen (our data), and the ample evidence that LCs that have
migrated to LN are profoundly immunostimulatory, we examined
whether LC could present antigen in an immunostimulatory way
to skin resident Tem cells, a population that a LC would certainly
encounter during a recall immune response prior to migration
to LN.
Candida antigen, via skin test, has been used clinically as
a measure of immunocompetence. Typically, >75% of humans
will have a positive skin test to C. albicans 48 hr after intradermal
injection (Esch and Buckley, 1988). This time point is consistent
with a memory immune response, and our unpublished data
suggests that it is mediated by skin resident Tem cells specific
for C. albicans. Thus, we reasoned that most individuals would
have skin resident Tem cells that respond to C. albicans. We
next examined whether LCs could present C. albicans to skin
resident Tem cells. The addition of C. albicans to cultures of
autologous LCs and skin resident memory T cells induced
significantly more T cell proliferation than in its absence. Under
these circumstances, two populations of T cells proliferated.
First was the CD4+CD25+FoxP3+CD127 cell population that
proliferated in the absence of C. albicans antigen. But in the
presence of C. albicans, a second population of T cells prolifer-
ated; these were FoxP3lo and CD127+, and they produced the
effector cytokines IFN-g and IL-17 (Acosta-Rodriguez et al.,
2007). The cells that proliferated were also of a phenotype
that suggested C. albicans specificity by TCR Vb (Devore-Carter
et al., 2008; Walsh et al., 1996). This latter population consists
of skin resident Tem cells specific for C. albicans, and if their
proliferation was blunted by the concurrent proliferation of
skin-resident memory Treg cells, it did not occur to a substantial
degree.
Given the abundance of skin resident memory T cells in normal
skin, many of them specific for normal skin microbial flora (Clark,
2010; Clark et al., 2006a), it stands to reason that the activation of
these cells must be tightly controlled. Our data are consistent
with a model wherein LCs in normal intact skin favor constitutive
local proliferation and activation of skin resident memory Treg
cells, thus providing a brake on inappropriate activation of skin
resident Tem cells in normal skin, whether to autoantigens of
foreign antigens. However, this brake appears to be readily
cast aside when a pathogen is encountered, as would occur
when the physical epidermal barrier is breached or disrupted
and innate immune danger signals are provided. Under these
conditions, LCs are then capable of presenting antigen in an
immunogenic fashion to skin resident Tem cells. Our data also
suggest that there is a threshold of antigen below which LCs
induce Treg cell proliferation, but above which LCs induce Tem
cell activation and proliferation. Thus, depending upon the bio-
logical context, LCs can function to maintain peripheral toler-
ance, but also have the capacity to activate protective skin resi-
dent memory T cells that can mount an effective host response
to pathogen.882 Immunity 36, 873–884, May 25, 2012 ª2012 Elsevier Inc.EXPERIMENTAL PROCEDURES
Isolation of Cells from Skin
Acquisition of skin samples and all scientific studies were approved by the
Institutional Review Board of the Partners Human Research Committee.
Samples of normal adult human skin were obtained as discarded human tissue
from cutaneous surgeries. T cells were isolated from skin with short-term
explant (5 days) cultures as previously described (Clark et al., 2006a). No exog-
enous cytokines were added. LCs and dermal DCs were purified from normal
human skin (Zaba et al., 2007). Subcutaneous fat was excised, and remaining
tissue was washed with PBS. The dermal layer was heavily scored with
a scalpel and incubated with 1 mg/ml type 1 collagenase (Invitrogen), 1 mg/
ml dispase (Invitrogen), and penicillin-streptomycin solution overnight at
37C. Epidermal and dermal sheets were separated and placed in RPMI
1640 supplemented with 10% pooled human serum (Cellgro Mediatech),
0.1% gentamicin reagent solution (Invitrogen), and 1% 1M HEPES buffer
(Sigma-Aldrich). After 48 hr at 37C, cells were collected and filtered
with 40 mm cell strainers (BD Biosciences) and then enriched with a Ficoll-
diatrizoate gradient (GE Healthcare Bio-Sciences). LCs were further purified
by positive selection with anti-CD1a MACS (Miltenyi-Biotec). Dermal
DCs were purified by positive selection with BDCA1+ isolation kit (Miltenyi-
Biotec).
Antibodies
All antibodies used for immunofluorescence and FACS are listed in Table S1.
Immunofluorescence
Five-micrometer-thick sections of formalin-fixed, paraffin-embedded tissues
from normal human skin were cut, deparaffinized, and subjected to a heat-
induced epitope retrieval step. Slides were rinsed in cool running water,
washed in Tris-buffered saline (pH 7.4) before incubation with primary anti-
bodies, and then incubated appropriate secondary antibodies: Alexa Fluor
488-conjugated anti-mouse or rat or Alexa Fluor 594-conjugated anti-mouse.
Additional negative controls were performed by adding isotype mouse anti-
bodies as primary antibodies. After subsequent washing, the sections were
mounted with Prolong Gold antifade reagent with DAPI (Invitrogen) and
covered with a coverslip. Immunofluoresecence reactivity was viewed on an
Olympus BX51/52 system microscope coupled to a Cytovision System
(Applied Imaging).
Candida albicans
C. albicans were seeded in RPMI medium plus 10% (vol/vol) FCS in a 24-well
plate. The plate was incubated for 2 hr at 65C to heat-inactivated yeast and
was cooled before used in experiments.
Analysis of T Cell Proliferation
For recall responses, skin isolated T cells were stained with 2 mM CFSE
(Molecular Probes) at 37C for 3 min (Parish et al., 2009). CFSE-labeled
T cells were washed three times and then were cultured (5 3 104 per well)
in 96-well plates in RPMI medium supplemented with 10% pooled human
serum, to which autologous LCs or dermal DCs (2.5 3 104/well) were added.
In some experiments, heat-killed C. albicans (5 3 104) was added to the
coculture.
Blocking Experiments
Purified anti-CD80, CD86, HLA DR-DP-DQ, HLA DR, HLA DP, and HLA DQ,
HLA A,B,C, CD1a, IL-2, and IL-15Ra or isotypes were added to skin DCs
and the plate were kept for 30 min at 4C and then washed before T cells
were added.
Regulatory T Cell Assay
Regulatory T cells were isolated after 6 days of coculture with LCs, by using the
CD4+CD25+CD127 dim/ regulatory T cell isolation kit II (Miltenyi Biotec). T
responders CD4+CD25 were isolated from normal skin explant culture.
CFSE-labeled CD4+CD25 (effectors) and CD4+ CD25+ CD127 (suppres-
sors) T cells (2.5 3 103 per well) were stimulated with plate-bound anti-CD3
(clone UCHT1, BD PharMingen) used at a concentration of 1 mg/ml and coated
in PBS for 2–4 hr at 37C, in presence of irradiated T cells depleted PBMCs
Immunity
LCs Activate Skin Resident Regulatory T Cells(2.5 3 104 per well). All cells were cultured in a final volume of 200 ml. Pro-
liferation was monitored by CFSE dilution on day 5 or by pulsing (18 hr) each
well with 1 mCi of [3H]thymidine (Perkin Elmer) as described previously
(Baecher-Allan and Hafler, 2006).
Statistics
Statistical significance was calculated with the two-tailed Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures and one table and can be found with this article online at
doi:10.1016/j.immuni.2012.03.018.
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